Sclerostin: a candidate biomarker of SCI-induced osteoporosis
about
A Rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: Perspectives and considerations for spinal cord injury.Early exercise after spinal cord injury ('Switch-On'): study protocol for a randomised controlled trialSerum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral DensitometryHow Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.The clinical utility of bone marker measurements in osteoporosis.The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor.Clinical utility of serum sclerostin measurements.Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.Associations between lean mass and leptin in men with chronic spinal cord injury: Results from the FRASCI-muscle study.
P2860
Q34197843-AB0A9048-2A9E-4914-812F-A1539C798ED4Q35060389-BD97894F-2E65-41C5-BBAF-884E5E2A00DFQ36685956-E73FB131-AAA8-4A27-A27E-319ED411AEF4Q36880655-1C04A029-749A-45FB-8AFB-ADE8F06B47EDQ36885350-C45B23BE-3D06-4A35-936D-86BE24232A31Q37153332-1C141FFE-17BB-4D69-8897-128395DDC65FQ37291429-38ADC0E2-C55F-4F66-845E-6E8ACD804753Q37605570-59C89945-6329-443B-8A0B-03A38D6EC64EQ39030288-C3F09573-A4C5-4513-AE7B-1EA3C4AC676FQ47837437-ED73E6BE-4C87-4516-B49C-BABA508B80D5Q50927799-063E0D7C-650F-414C-8DEA-7DFAADD0249EQ53838121-E7CFC365-BAE8-443A-A11A-4A6831550518Q55453436-8ED71018-EC2F-4D11-820E-23F973577A0B
P2860
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@ast
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@en
type
label
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@ast
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@en
prefLabel
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@ast
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@en
P2093
P2860
P1476
Sclerostin: a candidate biomarker of SCI-induced osteoporosis
@en
P2093
A A Lazzari
E Garshick
R A Battaglino
S Sudhakar
P2860
P2888
P304
P356
10.1007/S00198-012-2072-0
P407
P577
2012-07-17T00:00:00Z